Strongest Bluetooth integration7
10-meter range is more than 50% further than other CGMs7.
Consensus Error Grid for the FreeStyle Libre 3 system compared
with reference4
MARD=mean absolute relative difference; YSI=Yellow Springs
Instruments; glucose sensing technology reliability defined by
signal connection.
The FreeStyle Libre 3 system is accurate3, stable and
consistent over 14 days – no finger pricks5, no user
calibration, no code entry.
Excellent accuracy in the low through
high glucose ranges3
YSI Plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer
Overall
performance3
With readings every minute, the FreeStyle Libre 3 system provides 5x faster readings and alarms6 than other
leading brands and is the most reliable CGM for signal strength.7,8
Example: Glucose is dropping at 3mg/dL per minute. The low glucose alarms is set at 70 mg/dL.
The FreeStyle Libre 3 system delivers performance your patients can count on – so they won't miss a low glucose
alarm8 or possible hypo.
10-meter range is more than 50% further than other CGMs7.
15-day data storage makes data gaps a thing of the past.
With outstanding accuracy,3 best-in-class connectivity7 and readings every minute, patients can act faster to
reduce hypoglycaemia and improve overall glucose control10-14.
FreeStyle Libre 2 significantly
reduced time spent below target
range (<70 mg/dL) by 43 minutes
per day in people with T1D10
Reduces nocturnal hypoglycaemia
in T2D (<70 mg/dL, time in hour,
from 11:00 pm to 6:00 am)
(p<0.0001)11
Reduces serious hypoglycaemia in
T2D (<55 mg/dL, time in hour, within
24 hours)
(p<0.0014)11
0.55% average reduction in A1c
observed at 2-4 months, sustained
for 12 months13,14
People with T1D increased their time
in range by more than 2 hours per
day using FreeStyle Libre 2
compared to SMBG10
Outstanding accuracy across
multiple measures, including
strong low-end performance3
Real-time readings updated
every minute—5x faster than
any other CGMs15
Significant improvement in
clinical outcomes10-12, φ
φStudies data are collected with the FreeStyle Libre system or FreeStyle Libre 2 system and is applicable to the FreeStyle Libre 3 system based on technological similarities.
* Data on file, Abbott Diabetes Care, Inc. Based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for other leading personal use sensor-based glucose monitoring systems.
References & Disclaimers
Alla oleva "Kyllä"-linkki vie sinut muulle kuin Abbott Laboratories -sivustolle. Linkit muille verkkosivustoille eivät ole Abbott Laboratoriesin hallinnassa, eikä Abbott Laboratories ole vastuussa tällaisten verkkosivustojen sisällöstä tai sellaisista linkeistä. Abbott Laboratories tarjoaa nämä linkit sinulle vain avuksi, eikä minkään linkin lisääminen tarkoita, että Abbott Laboratories hyväksyy sivuston.
Haluatko poistua tältä sivulta?
Tämä on tuotekohtainen verkkosivusto, joka on tarkoitettu vain terveydenhuollon ammattilaisille Suomessa. Jos asut toisessa maassa, ota yhteyttä paikalliseen Abbott-toimistoon saadaksesi maatasi koskevat oikeat tuotetiedot.
PYSY YHTEYDESSÄ